CardioMEMS expands intrasac pressure instrument to US TAA (thoracic aortic aneurysm) market:
This article was originally published in Clinica
Extending the market of its EndoSure pressure-measuring system beyond use in aortic aneurysm repair, CardioMEMS has gained US clearance to also use the wireless product during thoracic aortic aneurysm (TAA) repair. The device, designed to measure vital medical parameters such as mean pressure, systolic pressure, diastolic pressure, heart rate and cardiac output, is comprised of an implanted sensor and an external electronics module. The EndoSure sensor is inserted during the minimally-invasive cardiovascular repair of an aneurysm via a catheter into the aneurysm sac, where it measures and communicates pressure information to an external electronics module. The information is processed in real time and displayed as a pressure waveform, according to the Atlanta, Georgia firm.
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.